mRNA vaccination against SARS-CoV-2 was tied to a 57% and 73% lower risk of having at least one or two long-COVID symptoms, ...
In the early, uncertain days of the coronavirus pandemic, scientists delivered one comforting pronouncement: The virus that ...
The widely used PCR tests continue to detect infection, including infection with Omicron, as we have seen with other variants as well Corticosteroids and IL6 Receptor Blockers will still be ...
The World Health Organization (WHO) Tuesday admitted Omicron variant of the coronavirus was already the dominant one worldwide, accounting for almost 60% of the cases. The new strain, which two ...
According to two new works carried out in Japan and Hong Kong, which have not yet been reviewed by other researchers, under experimental conditions, the OMICRON variant of the coronavirus survives ...
Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
As South Korea battled a spike in flu cases, misinformation swirled online that the country was suffering a resurgence of the Omicron XBB coronavirus variant, which was "five times stronger" and "more ...
Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.
"Vaccination is the exit strategy from omicron," WHO emergencies chief Dr. Michael Ryan said. Ryan said the explosive surge of cases in China was not exclusively due to the lifting of many of the ...
The following is a summary of “60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden,” ...